Allergan: we’ve transferred the patents for our dry-eye drug Restasis to the St. Regis Mohawk tribe, so now the Patent Trial and Appeal Board and our competitors can just go take a hike. The move follows a January decision by the PTAB to drop “a case against the University of Florida citing its sovereign immunity […]
Drug company hands patents over to Indian tribe is a post from Overla
Under a novel deal, Allergan will pay the Saint Regis Mohawk tribe $13.75 million. In exchange, the tribe will claim sovereign immunity as grounds to dismiss a patent challenge.
Allergan has disclosed that it transferred title to six of its contested eye drug patents to the St Regis Mohawk band in upstate New York, in a bid to use the band's sovereign immunity to prevent generic pharma companies from draggi...
(Reuters) - U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, Restasis.
(Reuters) - Allergan Plc will transfer to the Saint Regis Mohawk Tribe rights to its blockbuster Restasis dry-eye treatment, the drugmaker said on Friday, in an unusual deal to protect it from patent challenges.